Norman W. Barton

7.1k total citations · 1 hit paper
98 papers, 5.1k citations indexed

About

Norman W. Barton is a scholar working on Physiology, Molecular Biology and Cell Biology. According to data from OpenAlex, Norman W. Barton has authored 98 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Physiology, 29 papers in Molecular Biology and 21 papers in Cell Biology. Recurrent topics in Norman W. Barton's work include Lysosomal Storage Disorders Research (59 papers), Carbohydrate Chemistry and Synthesis (17 papers) and Glycosylation and Glycoproteins Research (16 papers). Norman W. Barton is often cited by papers focused on Lysosomal Storage Disorders Research (59 papers), Carbohydrate Chemistry and Synthesis (17 papers) and Glycosylation and Glycoproteins Research (16 papers). Norman W. Barton collaborates with scholars based in United States, Sweden and Denmark. Norman W. Barton's co-authors include Roscoe O. Brady, Gary J. Murray, James M. Dambrosia, Raphael Schiffmann, Suvimol Hill, Henry J. Mankin, Samuel H. Doppelt, Roscoe O. Brady, Raji P. Grewal and Charles E. Argoff and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Norman W. Barton

95 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's Disease

1991 981 citations Norman W. Barton, Roscoe O. Brady et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Norman W. Barton United States	40	3.5k	1.7k	1.6k	1.4k	1.0k	98	5.1k
Robin Lachmann United Kingdom	43	3.4k 1.0×	1.8k 1.1×	1.2k 0.7×	1.5k 1.1×	1.0k 1.0×	129	6.3k
M. Elleder Czechia	32	2.7k 0.8×	1.4k 0.8×	1.1k 0.7×	885 0.7×	570 0.6×	194	4.1k
Anna Tylki‐Szymańska Poland	39	4.1k 1.2×	1.6k 0.9×	1.4k 0.8×	1.8k 1.4×	1.2k 1.1×	263	5.4k
Eugen Mengel Germany	42	4.0k 1.1×	960 0.6×	802 0.5×	1.3k 0.9×	1.1k 1.0×	137	4.7k
Ari Zimran Israel	46	6.4k 1.8×	2.5k 1.5×	3.3k 2.0×	2.4k 1.8×	2.4k 2.3×	267	7.6k
Nathalie Guffon France	35	5.2k 1.5×	1.2k 0.7×	914 0.6×	2.4k 1.7×	1.1k 1.0×	138	6.5k
Yoshikatsu Eto Japan	38	2.1k 0.6×	1.7k 1.0×	673 0.4×	764 0.6×	532 0.5×	225	4.5k
Tadao Orii Japan	48	4.2k 1.2×	2.7k 1.6×	820 0.5×	1.9k 1.4×	1.1k 1.1×	251	7.1k
Emil Kakkis United States	37	3.5k 1.0×	1.1k 0.6×	598 0.4×	1.7k 1.2×	623 0.6×	73	5.0k
Joseph Muenzer United States	40	5.2k 1.5×	1.4k 0.8×	843 0.5×	2.3k 1.7×	805 0.8×	128	6.9k

Countries citing papers authored by Norman W. Barton

Since Specialization

Citations

This map shows the geographic impact of Norman W. Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman W. Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman W. Barton more than expected).

Fields of papers citing papers by Norman W. Barton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman W. Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman W. Barton. The network helps show where Norman W. Barton may publish in the future.

Co-authorship network of co-authors of Norman W. Barton

This figure shows the co-authorship network connecting the top 25 collaborators of Norman W. Barton. A scholar is included among the top collaborators of Norman W. Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman W. Barton. Norman W. Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kusuda, Satoshi, et al.. (2026). Randomised al.Phase 2b trial of rhIGF-1/rhIGFBP-3 (OHB-607) for bronchopulmonary dysplasia prevention in preterm neonates: study protocol. BMJ Paediatrics Open. 10(1). e004196–e004196.

Zhang, Yuan, Rhonda Souvenir, Ronghui Xia, et al.. (2025). Sex Differences in Ketogenic Diet Response Reveal Gonadal Hormone Interaction With FGF21 in Mice. Journal of the Endocrine Society. 9(10). bvaf131–bvaf131. 1 indexed citations

Farah, Mohamed H., Christine í Dali, Samuel Groeschel, et al.. (2023). Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy. Annals of Clinical and Translational Neurology. 11(2). 328–341. 4 indexed citations

Holmqvist, Bo, Olga Göransson, Magdaléna Vaváková, et al.. (2023). Characterization of choroid plexus in the preterm rabbit pup following subcutaneous administration of recombinant human IGF-1/IGFBP-3. Fluids and Barriers of the CNS. 20(1). 59–59. 3 indexed citations

Salamat‐Miller, Nazila, M. Turner, Amey Bandekar, et al.. (2022). Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications. World Journal of Pediatrics. 19(1). 58–67.

Albertine, Kurt H., Mar Janna Dahl, Zhengming Wang, et al.. (2022). Pilot dose-ranging of rhIGF-1/rhIGFBP-3 in a preterm lamb model of evolving bronchopulmonary dysplasia. Pediatric Research. 93(6). 1528–1538. 7 indexed citations

Salamat‐Miller, Nazila, Christopher McPherson, Paul A. Salinas, et al.. (2021). Development of Protein-Specific Analytical Methodologies to Evaluate Compatibility of Recombinant Human (rh)IGF-1/rhIGFBP-3 with Intravenous Medications Co-Administered to Neonates. Journal of Pharmaceutical Sciences. 111(5). 1486–1496. 3 indexed citations

Hellström, Ann, Boubou Hallberg, Ingrid Hansen‐Pupp, et al.. (2016). Determination of optimal dosing of rhIGF-1/rhIGFBP-3 to establish and maintain physiological intrauterine serum IGF-1 levels in preterm infants. Investigative Ophthalmology & Visual Science. 57(12). 6278–6278. 1 indexed citations

Mistry, Pramod K., Grisel Lopez, Raphael Schiffmann, et al.. (2016). Gaucher disease: Progress and ongoing challenges. Molecular Genetics and Metabolism. 120(1-2). 8–21. 117 indexed citations

10.

Desnick, Robert J., Norman W. Barton, Gregory Grabowski, et al.. (2016). Roscoe Owen Brady, MD: Remembrances of co-investigators and colleagues. Molecular Genetics and Metabolism. 120(1-2). 1–7. 2 indexed citations

11.

Grewal, Raji P., et al.. (1997). Liver biopsies in patients with lysosomal storage disease: Experience with effective sedation. The Indian Journal of Pediatrics. 64(6). 887–891. 3 indexed citations

12.

Grabowski, Gregory A., Howard M. Saal, Richard Wenstrup, & Norman W. Barton. (1996). Gaucher disease: a prototype for molecular medicine. Critical Reviews in Oncology/Hematology. 23(1). 25–55. 26 indexed citations

13.

Ro, Brady & Norman W. Barton. (1994). Enzyme Replacement Therapy for Gaucher Disease: Critical Investigations beyond Demonstration of Clinical Efficacy. Biochemical Medicine and Metabolic Biology. 52(1). 1–9. 27 indexed citations

14.

Brady, Roscoe O., Norman W. Barton, & Gregory A. Grabowski. (1993). The Role of Neurogenetics in Gaucher Disease. Archives of Neurology. 50(11). 1212–1224. 80 indexed citations

15.

Castronovo, Frank P., Kenneth A. McKusick, Samuel H. Doppelt, & Norman W. Barton. (1993). Radiopharmacology of inhaled 133Xe in skeletal sites containing deposits of Gaucher cells. Nuclear Medicine and Biology. 20(5). 707–714. 7 indexed citations

16.

Hill, Suvimol, Alexander Ling, Karen Patterson, et al.. (1992). Gaucher disease: abdominal MR imaging findings in 46 patients.. Radiology. 184(2). 561–566. 48 indexed citations

17.

Grewal, Raji P. & Norman W. Barton. (1992). Fabry's disease presenting with stroke. Clinical Neurology and Neurosurgery. 94(2). 177–179. 20 indexed citations

18.

Barton, Norman W., Roscoe O. Brady, Samuel H. Doppelt, et al.. (1992). Dose-dependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher disease. The Journal of Pediatrics. 120(2). 277–280. 47 indexed citations

19.

Fink, John K., Paula Ravin, Charles E. Argoff, et al.. (1989). Tetrahydrobiopterin administration in biopterin‐deflcient progressive dystonia with diurnal variation. Neurology. 39(10). 1393–1393. 25 indexed citations

20.

Shawker, Thomas H., Richard Chang, Brian S. Garra, et al.. (1988). An unusual anomalous intrahepatic connection between the left portal vein and internal mammary veins. Journal of Clinical Ultrasound. 16(6). 429–435. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact